Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Ten-Year Trends of Clinicopathologic Features and Surgical Treatment of Lung Cancer in China

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Intrathoracic Splenosis Without Clinical Evidence of Diaphragmatic Rupture

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Exploring Shared Mental Models of surgical teams in Video-Assisted Thoracoscopic Surgery lobectomy

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Postmarket Experience With HeartMate 3 Left Ventricular Assist Device: 30-Day Outcomes From the ELEVATE Registry

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. The Optimal Treatment for Stage IIIA-N2 Non-small-cell Lung Cancer: A Network Meta-analysis

    Research output: Contribution to journalReviewResearchpeer-review

  1. Benefits of omitting chest drain after thoracoscopic major lung resection

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Society for Translational Medicine consensus on postoperative management of EGFR-mutant lung cancer (2019 edition)

    Research output: Contribution to journalReviewResearchpeer-review

  3. A Nomogram for Predicting Cancer-Specific Survival of TNM 8th Edition Stage I Non-small-cell Lung Cancer

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Characteristics of 252 patients with bronchopulmonary neuroendocrine tumours treated at the Copenhagen NET Centre of Excellence

    Research output: Contribution to journalJournal articleResearchpeer-review

  • AME Thoracic Surgery Collaborative Group
View graph of relations

Background: Lung cancer has changed significantly during the past 2 decades in its epidemiology and treatment. This retrospective analysis used data from 7 major areas of China over 10 years to evaluate clinicopathologic and surgical treatment trends of lung cancer in China during the past decade. Methods: Data from 7184 patients with primary lung cancer who were treated between 2005 and 2014 in 8 provinces of China were retrospectively collected. Their clinicopathologic features and surgical treatment information were recorded. Simple linear regression models and the Cochrane-Armitage trend test were used to assess temporal trends. Results: The proportion of female patients (from 57.4% to 59.6%; P <.001) and nonsmoking patients (from 37.1% to 48.9%; P <.001) and of patients with a family history of malignant tumors (from 7.0% to 11.5%; P <.001) increased significantly. The percentage of adenocarcinomas increased significantly (from 36.4% to 53.5%; P <.001), with a decrease in squamous cell carcinomas (from 45.4% to 34.4%; P <.001). After 2008, the application of minimally invasive surgery significantly increased in China (from 2.4% in 2008 to 34.4% in 2014; P <.001), with a decline in the rate of conversion to open operation (from 14.3% in 2008 to 4.8% in 2014; P =.146) and an increase in the proportion of systematic mediastinal lymph node dissection (from 50.0% in 2008 to 84.1% in 2014; P =.001). Conclusions: This study investigated recent 10-year trends in the clinicopathologic features and surgical treatment of lung cancer in China and found significant important changes. These findings provide valuable information and evidence for the future control of the disease in China.

Original languageEnglish
JournalThe Annals of thoracic surgery
Volume109
Issue number2
Pages (from-to)389-395
Number of pages7
ISSN0003-4975
DOIs
Publication statusPublished - Feb 2020

ID: 59289049